Dr. Matthew Enkema is a Seattle, Washington based psychologist who is specialized in General Psychology. His current practice location is 1200 5th Ave Ste 800, Seattle. Patients can reach him at 206-755-8825. Dr. Matthew Enkema is PHD in General Psychology and his NPI number (Unique professional ID assigned by NPPES) is 1790306520. Dr. Matthew Enkema is specialized in psychological testing and evaluating or assessing patient's personal characteristics, such as intelligence, personality, abilities, interests, aptitudes, and neuropsychological functioning. Accordingly, he performs counseling, psychoanalysis, psychotherapy, hypnosis, biofeedback, and behavior analysis and therapy. He can diagnose and treat mental and emotional disorder or disability, alcoholism and substance abuse, disorders of habit or conduct, as well as of the psychological aspects of physical illness, accident, injury, or disability by psycheducational evaluation, therapy, remediation, and consultation.
Complete Profile:
Dr. Matthew Enkema speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790306520
NPI Enumeration Date:
04 May, 2020
NPI Last Update On:
22 Feb, 2023
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Matthew Enkema 1200 5th Ave Ste 800, Seattle, Washington
Zip:
98101-3136
Phone Number:
206-755-8825
Patients can reach Dr. Matthew Enkema at 1200 5th Ave Ste 800, Seattle, Washington or can call to book an appointment on 206-755-8825.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.